Kebreten F. Manaye to Parkinson Disease
This is a "connection" page, showing publications Kebreten F. Manaye has written about Parkinson Disease.
Connection Strength
0.532
-
Tizabi Y, Getachew B, Mendieta L, Palafox-S?nchez V, Tsytsarev V, Manaye KF, Tinkov AA, da Silva VDA, Aschner M. A Narrative Review on the Role of Microbiota and Microglia in Premotor Symptoms of Parkinson's Disease. Neurotox Res. 2025 Oct 31; 43(6):45.
Score: 0.199
-
Getachew B, Csoka AB, Copeland RL, Manaye KF, Tizabi Y. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease. Neurotox Res. 2023 Apr; 41(2):141-148.
Score: 0.164
-
Tizabi Y, Getachew B, Csoka AB, Manaye KF, Copeland RL. Novel targets for parkinsonism-depression comorbidity. Prog Mol Biol Transl Sci. 2019; 167:1-24.
Score: 0.129
-
German DC, Manaye KF, White CL, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DM. Disease-specific patterns of locus coeruleus cell loss. Ann Neurol. 1992 Nov; 32(5):667-76.
Score: 0.020
-
German DC, Manaye KF, Sonsalla PK, Brooks BA. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci. 1992 May 11; 648:42-62.
Score: 0.020